Specific cells within the immune system could help explain why younger people are more susceptible to variant Creutzfeldt-Jakob disease — a rare, degenerative, fatal brain disorder. Patients diagnosed with variant CJD are, on average, 28 years old but it has been unclear why older people are not as affected by the disease.